"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
Descriptor ID |
D018450
|
MeSH Number(s) |
C23.550.291.656
|
Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 0 | 3 | 3 |
1997 | 0 | 2 | 2 |
1998 | 0 | 1 | 1 |
1999 | 0 | 2 | 2 |
2000 | 0 | 4 | 4 |
2001 | 0 | 1 | 1 |
2002 | 0 | 5 | 5 |
2003 | 0 | 9 | 9 |
2004 | 0 | 6 | 6 |
2005 | 0 | 3 | 3 |
2006 | 0 | 12 | 12 |
2007 | 0 | 11 | 11 |
2008 | 0 | 13 | 13 |
2009 | 1 | 12 | 13 |
2010 | 1 | 11 | 12 |
2011 | 0 | 7 | 7 |
2012 | 0 | 13 | 13 |
2013 | 3 | 17 | 20 |
2014 | 2 | 19 | 21 |
2015 | 2 | 24 | 26 |
2016 | 0 | 11 | 11 |
2017 | 2 | 24 | 26 |
2018 | 5 | 25 | 30 |
2019 | 2 | 29 | 31 |
2020 | 1 | 22 | 23 |
2021 | 0 | 10 | 10 |
2022 | 0 | 1 | 1 |
2023 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Localized cardiac small molecule trajectories and persistent chemical sequelae in experimental Chagas disease. Nat Commun. 2023 10 25; 14(1):6769.
-
Vascular mechanisms leading to progression of mild cognitive impairment to dementia after COVID-19: Protocol and methodology of a prospective longitudinal observational study. PLoS One. 2023; 18(8):e0289508.
-
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023 06 13; 329(22):1934-1946.
-
Glioblastoma remodelling of human neural circuits decreases survival. Nature. 2023 May; 617(7961):599-607.
-
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma. N Engl J Med. 2023 Mar 02; 388(9):813-823.
-
Genetic load in incomplete lupus erythematosus. Lupus Sci Med. 2023 01; 10(1).
-
Peripheral Blood DNA Methylation-Based Machine Learning Models for Prediction of Knee Osteoarthritis Progression: Biologic Specimens and Data From the Osteoarthritis Initiative and Johnston County Osteoarthritis Project. Arthritis Rheumatol. 2023 01; 75(1):28-40.
-
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134. J Clin Oncol. 2023 01 10; 41(2):186-197.
-
The intersection of COVID-19 and autoimmunity. J Clin Invest. 2021 12 15; 131(24).
-
Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study. Gynecol Oncol. 2021 11; 163(2):392-397.